Carlos Balmaceda

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Health Information

Peritoneal Dialysis

Tyrosine Kinase

Rheumatoid Arthritis Patients

Top Venues

Expert review of pharmacoeconomics & outcomes research

PharmacoEconomics - open

Journal of comparative effectiveness research

This page only lists publications with an associated author ORCID identifier.

Publications

Nicolás Armijo, Constanza Salas, Nazareth Espinoza, Manuel Espinoza, Carlos Balmaceda
Budget impact analysis of durvalumab consolidation therapy vs no consolidation therapy after chemoradiotherapy in stage III non-small cell lung cancer in the context of the Chilean health care system. PloS one 19 (7) (2024)
Nicolás Armijo, Constanza Salas, Nazareth Espinoza, Manuel Espinoza, Carlos Balmaceda
Budget impact analysis of durvalumab consolidation therapy vs no consolidation therapy after chemoradiotherapy in stage III non-small cell lung cancer in the context of the Chilean health care system. PloS one 19 (7) (2024)
Nicolás Armijo, Constanza Salas, Nazareth Espinoza, Manuel Espinoza, Carlos Balmaceda
Budget impact analysis of durvalumab consolidation therapy vs no consolidation therapy after chemoradiotherapy in stage III non-small cell lung cancer in the context of the Chilean health care system. PloS one 19 (7) (2024)
Alfredo Palacios, Federico Rodriguez Cairoli, Dario Balan, Carlos Balmaceda, Federico Augustovski, Andrés Pichón-Riviere, Ariel Esteban Bardach
Budget impact analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring System® in patients with diabetes mellitus type 1 in Chile. Expert review of pharmacoeconomics & outcomes research (2023)
Alfredo Palacios, Federico Rodriguez Cairoli, Dario Balan, Carlos Balmaceda, Federico Augustovski, Andrés Pichón-Riviere, Ariel Esteban Bardach
Budget impact analysis of the freestyle libre flash continuous glucose monitoring system® in patients with diabetes mellitus type 1 in Chile. Expert review of pharmacoeconomics & outcomes research 23 (3) (2023)
Alfredo Palacios, Federico Rodriguez Cairoli, Dario Balan, Carlos Balmaceda, Federico Augustovski, Andrés Pichón-Riviere, Ariel Esteban Bardach
Budget impact analysis of the freestyle libre flash continuous glucose monitoring system® in patients with diabetes mellitus type 1 in Chile. Expert review of pharmacoeconomics & outcomes research 23 (3) (2023)
Alfredo Palacios, Federico Rodriguez Cairoli, Dario Balan, Carlos Balmaceda, Federico Augustovski, Andrés Pichón-Riviere, Ariel Esteban Bardach
Budget impact analysis of the freestyle libre flash continuous glucose monitoring system® in patients with diabetes mellitus type 1 in Chile. Expert review of pharmacoeconomics & outcomes research (2023)
Manuel Antonio Espinoza, Norberto Bilbeny, Tomas Abbott, Cesar Carcamo, Pedro Zitko, Paula Zamorano, Carlos Balmaceda
Cost analysis of chronic pain due to musculoskeletal disorders in Chile. PloS one 17 (10) (2022)
Antonio Ahumada-Canale, Constanza Vargas, Carlos Balmaceda, Francisco J Martinez-Mardones, José Cristian Plaza-Plaza, Shalom Charlie I Benrimoj, Victoria García-Cárdenas
Medication review with follow-up for cardiovascular outcomes: a trial based cost-utility analysis. Journal of comparative effectiveness research 10 (3) (2021)
Manuel Antonio Espinoza, Rubén Rojas, Alessandro Zaupa, Carlos Balmaceda
A Model-Based Economic Evaluation of Cladribine Versus Alemtuzumab, Ocrelizumab and Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activity in Chile. PharmacoEconomics - open 5 (4) (2021)